Clostridium difficile infection (CDI) 소화기내과 R4 신아리 1.

Slides:



Advertisements
Similar presentations
Building on Patient Safety Clostridium difficile practice opportunities Mary Ellen Scales RN MSN CIC Baystate Medical Center.
Advertisements

Clostridium Difficile Infectious Diarrhea
CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA VALERIE FLETCHER, M.D. INFECTIOUS DISEASES SOUTHERN OHIO MEDICAL CENTER August 2006.
Sherif Ibrahim, MD, MPH WVDHHR, BPH, OEPS Division of Infectious Disease Epidemiology 11/16/
Clostridium Difficile
Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC.
Clostridium Difficile (C.diff): Fast Facts. What is Clostridium difficile (C. diff)? C. diff is a bacteria that lives in the intestinal tract of about.
DIARRHOEAL DISEASES Causes of Over-indulgence in Chemical Long-term antibiotic Viral causes: # Rotavirus # Norwalk.
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
Epidemiology and Prevention of Clostridium difficile
Clostridium difficile infections (CDI) surveillance in Colorado Kelly R. Kast, MSPH.
TechLab Diarrheal Diseases in Underdeveloped Countries Worldwide Problem More than 10,000 deaths per day On average, about 18 diarrheal episodes per year.
Microbe of the Week Mycobacterium marinum The aquarium or fish tank disease,first reported in 1962 Rare but important if not treated Living example-Karen.
Gram positive Cocci Staphylococci Streptococci Enterococci Bacilli Bacillus Clostridia Corynebacteria.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 8 Antiinfective Agents.
PEPTIC ULCER DISEASE NRS452 Norhaini Majid.
Clostridium difficile Colitis. C. diff.—Gram stain.
Streptococcus pneumoniae Chapter 23. Streptococcus pneumoniae S. pneumoniae was isolated independently by Pasteur and Steinberg more than 100 years ago.
Clostridial infections *C.difficile is found as a part the normal bowel flora in 3-5% of the pooulation and even more commonly in hospitalized patients.
Management of Clostridium difficile Infections
1 What’s All the Fuss About Clostridium difficile? Peter C. Iwen, PhD, D(ABMM) Nebraska Public Health Laboratory
MICR 420 Emerging and Re-Emerging Infectious Diseases Lecture 4: C. difficile Dr. Nancy McQueen & Dr. Edith Porter.
Monday AM report
Inflammatory Bowel Disease Ulcerative colitis (UC) Kristina Blaslov Mentor: A. Žmegač Horvat.
Clostridium difficile Infection (CDI): Increasingly Severe and Rapidly Fatal Disease Requires High Certainty of Treatment Efficacy Dale N. Gerding, MD.
Big Bad Bugs in the Dialysis Unit Douglas Shemin, MD Kidney Diseases and Hypertension Division, Rhode Island Hospital.
Clostridium difficile: Shifting Sands of a Pesky Pathogen
What’s All the Fuss About Clostridium difficile? Peter C. Iwen, PhD, D(ABMM) Nebraska Public Health Laboratory.
Outline C. difficile infection Fecal microbiota
Preventing and Treating C.difficile Lisa Casey, M.D. Assistant Professor, UT Southwestern Medical Center TSGE / SGNA Annual Scientific Meeting September.
Non-Invasive Enteritis and Food Poisoning. FOODBORNE ILLNESS (Bacterial) Foodborne illness results from eating food contaminated with organisms or toxins.
Infectious Diarrheas - Overview Greatest cause of morbidity and mortality worldwide Scope of disease: 1993, E.coli 0157:H Cyclospora 1998.
Gram-Positive Bacilli Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan University of Jordan.
Clostridium perfringens The agent of - Gangrene - Food poisoning Bacteria features: GPB, Capsulate, non-motile. Spores: bulging Rapidly growing (doubling.
Case Presentation Thamer Abdullah Bin Traiki. Case Presentation A 44-year-old woman with a history of multiple complicated urinary tract infections requiring.
Life-Threatening Infections: Diagnosis and Antimicrobial Therapy Selection.
NYU Medical Grand Rounds Clinical Vignette Andy Levy, MD PGY-2 March 26, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Novel chimeric vaccines against Clostridium difficile infection
Clostridium difficile: An Emerging Threat
Pneumonia Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Introduction Infection involving the.
Clostridium difficile
Clostridium difficile Separating key facts from fiction S P Borriello
Pathogenesis of Infectious Diseases CLS 212: Medical Microbiology.
Clostridium Difficile BY: KELSEY COMBS AND ROSA CORDOVA.
Lec. No. 11 Dr. Manahil Clostridium difficile C. difficile is a gram positive, spore forming, obligate anaerobe. Colonies of the organism are about 4mm.
Clostridium difficile Ricardo A. Caicedo, M.D.. OBJECTIVES Introduction Epidemiology Clinical spectrum Diagnosis Treatment Prevention.
Jane Stockley Chris Catchpole Carole Clive November 2012.
VIRAL & FUNGAL INFECTIONS OF GIT Assist Prof Dr. Syed Yousaf Kazmi.
Clostridium difficile Prevention Strategies. Objectives: Identify Seriousness of Clostridium difficile infection. Surveillance strategies. Prevention.
Clostridium Difficile Infection:
Dept. of Infectious Diseases 杨绍基. Amebic dysentery Definition Parasitic disease, Entamoeba histolytica, trophozoites induce submucosal ulcerations abdominal.
Endo Spore Gram positive rods
Clostridium difficile infections
Pyogenic Liver Abscess 소화기내과 R4 신아리 MGR Disease Review.
© 2013 Pearson Education, Inc. Bell Ringer  What is an endospore, and what special characteristics do endospore forming bacteria have?
Complications in IBD for acute internal medicine S Sebastian.
<Review> Nosocomial Diarrhea:
JAMA Internal Medicine May 2015 Volume 175, Number5 R1 조한샘 / Prof. 이창균.
Clostridium difficile Infection Fellow 이시내. Clostridium difficile  An anaerobic gram-positive, spore-forming, toxin-producing bacillus.  Transmitted.
Clostridium Difficile Patients In the Endoscopy Center
Pathogenesis of Infectious Diseases
Gram-Positive Bacilli
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
Dr Asmaa fathy abdellah hassan
Bacillary Dysentery (shigellosis)
Clostridium difficile
David L. McCollum, J. Martin Rodriguez 
C.Difficile update – what you need to know in Primary Care
CLINICAL SOLVING PROBLEM
Presentation transcript:

Clostridium difficile infection (CDI) 소화기내과 R4 신아리 1

45 세 남자환자가 내원 5 일 동안 지속되는 점액성 수양성 설사를 주소로 내원하였다, 환자는 내원 2 주 전 Community Acquired Pneumonia 로 입원하여 Cephalosporin 정맥투여 및 Clarithromycin 경구투여 받고 증상 호전되어 내원 1 주 전에 퇴원하였으나, 내원 5 일전부터 점액성 수양성 설사를 보이고, 발열이 동반되어 내원 하였다. 2 Case

Why are we Concerned about C.difficile infection ?? 1) Increasing numbers of infection 2) Potential for severe disease 3) Emergence of hypervirulent strains that may be more transmissible and/or cause more severe disease e.g. ribotype NAP1/BI/027 4) Concerns over possible antibiotic resistance 5) Increasingly recognized as a major nosocomial pathogen capable of causing outbreaks 3 Introduction

Clostridium difficile infection (CDI) - Unique colonic disease that is acquired almost exclusively in association with antimicrobial use and consequent disruption of the normal colonic flora - Most commonly diagnosed diarrheal illness acquired in hospital - Ingestion of spores of C.difficile that vegetate, multiply, and secrete toxins, causing diarrhea and pseudomembranous colitis (PMC) 4 Introduction Harrison 18th Ch129, page

Epidemiology 5 N Engl J Med (2008) 359, 1932~-1940 Arch Surg (2007) 142, 624~631

Epidemiology 6 대한소화기학회지 (2010) 55, 대한소화기학회지 (2010) 55,

Epidemiology 7 Arch Surg (2007) 142, 624~631

Risk Factors 8 Risk factors 1) Age > 65 yrs 2) Severe underlying disease 3) Antimicrobial therapy 4) Nasogastric intubation 5) Chemotherapy 6) Anti-ulcer medications : PPIs (proton-pump inhibitors) 7) Long hospital stay or long-term care residency FrequentOccasionalRare Cephalosporins Penicillins Clindamycin Fluoroquinolones Macrolides Trimethoprim Sulfonamides Aminoglycosides Tetracyclines Chloramphenicol Metronidazole Vancomycin Gastroenterology (2009) 136,

Introduction 9

10

Pathogenesis 11 Gastroenterology (2009) 136,

Microbiology 12 Clostridium difficile : Anaerobe, Gram (+), Spore forming bacillus Pathogenicity of C.difficile 1) Toxin A (enterotoxin) - causes outpouring of fluid and watery diarrhea 2) Toxin B (cytotoxin) - damages colonic mucosa leading to pseudomemb. formation 3) Pathogenicity in a pathogenicity locus (PaLoc) of five genes J Clin Microbiol (2002) 40,

Microbiology 13 J Clin Microbiol. (2008) 46, 1530–1533 Current epidemic strain of C.difficile 1) BI/NAP1/027, toxinotype III 2) Historically uncommon – epidemic since ) More virulent : Increased toxin A and B production More resistant to fluoroquinolones : higher MICs Increased sporulation

Microbiology 14 In vitro production of toxins in epidemic strain Lancet. (2005) 366, x16 x23

Microbiology 15

16 Factors appear to influence clinical expression of disease - Virulence of the infecting strain - Host immune response Onset of Symptoms - > 80% : During antibiotic treatment (typically after 4-5 d of Tx) - < 20% : After inciting antibiotic discontinued (most within 4 wks, almost all within 12 wks) Clinical Manifestations Harrison 18th Ch129, page

17 Clinical Manifestations TypeDiarrheaOther SxP/Ex ASx. carrier Absent NL C.difficile associated diarrhea with colitis Diarrhea Fecal leukocyte (+) Occult bleeding (±) Hematochezia (rare) Anorexia, nausea, fever, leukocytosis Abd distention, tenderness Pseudo- membranous colitis Diarrhea more profuse than in colitis without pseudomemb. Fecal leukocyte (+) Occult bleeding (±) Hematochezia (rare) Anorexia, nausea, fever, leukocytosis ; more severe than in colitis without pseudomemb Marked abdominal tenderness, distention Fulminent colitis Diarrhea may be severe or diminished (d/t paralytic ileus & colonic dilatation) Lethargy, fever, tachycardia, abd pain; dilated colon/paralytic ileus may be demonstrated on plain abdomen film May present as acute abdomen; peritoneal signs suggest perforation Harrison 18th Ch129, page

18 Diagnosis History taking : Sx, Hx of antibiotics use Laboratory test - Cell culture cytotoxin test on stool - Enzyme immunoassay toxin test (toxin A or toxin A&B) in stool - Stool culture for C.difficile - PCR for C.difficile toxin B gene in stool Endoscopy : Sigmoidoscopy Harrison 18th Ch129, page

19 Diagnosis Laboratory tests CMAJ, (2004) 171, 51-58

Sigmoidoscopy Diagnosis 대한내과학회지, (2010) 78, AB C D

Diagnosis

Gross Finding Diagnosis NEJM (2005) 353, 2491 Histologic Finding (H&E,x400) At autopsy, the colon showed evidence of pseudomembranous colitis with multiple yellow plaques. Mushroom-shaped pseudomembrane “Volcano” lesion, H&E, x400

Treatment Gastroenterology (2009) 136,

Treatment Gastroenterology (2009) 136,

Treatment Gastroenterology (2009) 136,

Treatment Gastroenterology (2009) 136,

Treatment Gastroenterology (2009) 136,

Treatment Infect Control Hsp Epidemiol; SHEA-IDSA guideline (2010) 31,

Treatment N Engl J Med (2010) 362, 197~205

Treatment N Engl J Med (2011) 364, 422~431

Prevention Gastroenterology (2009) 136,